Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
With ‘lessons learned,’ Kite preps for key CAR-T launch
Gilead's Kite is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
Fraiser Kansteiner
Apr 28, 2026 11:30pm
FDA takes first steps in withdrawing approval of Amgen's Tavneos
Apr 28, 2026 11:37am
Lessons from the eye: How cell therapy is shaping the future of regenerative medicine
Brought to you by
ASTELLAS
Rocket nets $180M in priority review voucher sale
Apr 28, 2026 11:16am
AZ's Breztri picks up 2nd FDA nod, unlocking asthma market
Apr 28, 2026 10:47am
Haleon scores branding goal with star-studded soccer offensive
Apr 28, 2026 10:15am
More News
Novartis stands by $5B Pluvicto goal despite EU regulatory setback
Apr 28, 2026 10:10am
GSK’s Tesaro can’t trim AnaptysBio's Jemperli royalties: judge
Apr 28, 2026 8:41am
Mundipharma, CorMedix score trial victory for antifungal Rezzayo
Apr 27, 2026 3:52pm
Regulatory tracker: FDA clears new dosing for AZ's Saphnelo
Apr 27, 2026 3:07pm
